

Cover Story
Free
In recent years, Vinay Prasad, a young hematologist–oncologist at Oregon Health and Science University, has emerged as a premier critic of new directions in cancer medicine.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- Survivorship begins at diagnosis—cancer care system must recognize this
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
















